Find out more, call us now: +44 (0) 1234 419430, or email info@rapivd.com
Contract Research & Development
Working with you
when results really matter
Publications
​Dr Robert Porter is a pioneer in rapid in vitro diagnostics and in addition to his patents, he has been been published in several journals, papers and books.
​
-
R. A. Porter, Journal of Immunoassay, 2000, 21, 51-64.
-
R. Porter, P. van der Logt, S. Howell, M. Kyrolainen-Reay and A. Badley, Biosens Bioelectron, 2001, 16, 875-885.
-
J. E. Noble, L. Wang, E. Cerasoli, A. E. Knight, R. A. Porter, E. Gray, C. Howe, E. Hannes, P. Corbisier, J. Wang, L. Wu, I. Altieri, M. Patriarca, A. Hoffman, U. Resch-Genger, B. Ebert, J. Voigt, Y. Shigeri, M. S. Vonsky, L. A. Konopelko, A. K. Gaigalas and M. J. A. Bailey, Clinical Chemistry and Laboratory Medicine, 2008, 46, 1033-1045.
-
M. Panteghini, D. M. Bunk, R. H. Christenson, A. Katrukha, R. A. Porter, H. Schimmel, L. L. Wang, J. R. Tate and I. W. G. S. T, Clinical Chemistry and Laboratory Medicine, 2008, 46, 1501-1506.
-
R. Porter, A. Kabil, C. Forstern, C. Slevin, K. Kouwenberg, M. Szymanski and B. Birch, J. Immunoass. Immunoch., 2009,30, 428-440.
-
M. Szymanski and R. Porter, in XIX IMEKO World Congress, Lisbon, 2009, pp. 1738-1743.
-
D. M. B. Jillian R. Tate, Robert H. Christenson, Alexei Katrukh, James E. Noble, Robert A. Porter, Heinz Schimmel, Lili Wang And Mauro Panteghini, Pathology, 2010, 42, 402 - 408.
-
J. E. Noble, D. M. Bunk, R. H. Christenson, K. D. Cole, H. J. He, A. G. Katrukha, M. Panteghini, R. A. Porter, H. Schimmel, J. R. Tate and L. Wang, Clin Chem Lab Med, 2010, 48, 1603-1610.
-
M. Szymanski, A. P. F. Turner and R. Porter, Electroanalysis, 2010, 22, 191-198.
-
S. Thobhani, S. Attree, R. Boyd, N. Kumarswami, J. Noble, M. Szymanski and R. A. Porter, J. Immunol. Methods, 2010, 356, 60-69.
-
M. Szymanski, R. Porter, G. V. Dep, Y. Wang and B. G. Haggett, Phys Chem Chem Phys, 2011, 13, 5383-5387.
-
M. J. Whitcombe, I. Chianella, L. Larcombe, S. A. Piletsky, J. Noble, R. Porter and A. Horgan, Chem Soc Rev, 2011, 40, 1547-1571.
-
R. Porter, P. K. Wilson, M. Szymanski and S. Attree, Journal of Immunoassay and Immunochemistry, 2012, www.tandfonline.com/doi/full/10.1080/15321819.15322012.15725446.
-
J. Noble, S. Attree, A. Horgan, A. Knight, N. Kumarswami, R. Porter and G. Worsley, Analytical Chemistry, 2012 84, 8246-8252.
-
M. Szymanski, J. Noble, A. Knight, R. Porter and G. Worsley, Analytical Methods, 2013, 5, 187-191.
-
M. Szymanski and R. Porter, J Immunol Methods, 2013, 387 262-269.
-
P. K. Wilson, M. Szymanski and R. Porter, J Immunol Methods, 2013, 387, 302-307.
-
NobelJE, Wang L, Cerasoli E, Knight AE, Porter RA,Gray E, Howe C, Hannes E, Corbisier P, Wang J, Wu L, Altieri I, Patriarca M, Hoffman A, Resch-Genger U, Ebert B, Voigt J, Shigeri Y, Vonsky MS, Konopelko LA, Gaigalas AK, Bailey MJ International CCQM intercomparison study to identify sources of uncertainty for a fluorescent ELISA; CCLM e-journal.
-
Lathan Ball, H Carter, C Baker, R Porter. Toxicology Letters. 3rd October 2024. The development of rapid immunoassays for the urinary analysis of 1-hydroxypyrene glucuronide facilitate both laboratory and on-site polycyclic aromatic hydrocarbon biomonitoring.